SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950123-11-091242
Filing Date
2011-10-21
Accepted
2011-10-21 17:00:20
Documents
1
Group Members
ACM ALPHA CONSULTING MANAGEMENT AGACM ALPHA CONSULTING MANAGEMENT EST.ANDREAS KANDZIORAVERONIKA KANDZIORAZBIGNIEW LOBACZ

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A c23582sc13dza.htm SC 13D/A 73308
  Complete submission text file 0000950123-11-091242.txt   74971
Mailing Address 305 INDUSTRIAL PARKWAY SOUTH UNIT 3 AURORA ON L4G 6X7 P4 000000
Business Address 305 INDUSTRIAL PARKWAY SOUTH UNIT 3 AURORA ON L4G 6X7 P4 000000 905-841-2300
Helix BioPharma Corp (Subject) CIK: 0001305591 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A | Act: 34 | File No.: 005-86417 | Film No.: 111152960
SIC: 2834 Pharmaceutical Preparations

Mailing Address SIHLEGGSTRASSE 23 WOLLERAU V8 CH-8832
Business Address SIHLEGGSTRASSE 23 WOLLERAU V8 CH-8832 41 76 208 2084
ACM Alpha Consulting Management AG (Filed by) CIK: 0001531589 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A